Lee‐Jen Wei - Concepedia

Author

Lee‐Jen Wei

Harvard University ORCID

Also Known As

Andrew Rowland, Dr. Lim Wei, L. J Wei, L. J. WEI, L. J. Wei, L.J Wei, L.J. Wei, Laituo Wei, Lee-Jen J. Wei, Lee-Jen Wei

149

Publications

7.8K

Citations

H-Index

105

Concepts

All Affiliations

Harvard University Stanford University Brigham and Women's Hospital University of South Carolina Dana-Farber Cancer Institute

About

Lee‐Jen Wei is an author at Harvard University specializing in statistics, biostatistics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	12	15	967
2	Health Sciences	11	11	1.6K
3	Business	3	3	258
4	Law	2	2	553
5	Arts	1	1	41

Lee‐Jen Wei

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
Pooled Association Tests for Rare Variants in Exon-Resequencing Studies Alkes L. Price, Gregory V. Kryukov, Paul I.W. de Bakker, The American Journal of Human Genetics Genome-wide Association StudyGenotype-phenotype AssociationGeneticsGenetic EpidemiologyStatistical Genetics	2010	769
The Randomized Play-the-Winner Rule in Medical Trials Lee‐Jen Wei, S. D. Durham Journal of the American Statistical Association Field TrialGame TheorySequential Medical TrialTreatment EffectLaw	1978	437
dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data Ming Gang Lin, Lee‐Jen Wei, William R. Sellers, Bioinformatics	2004	373
Properties of the urn randomization in clinical trials Lee‐Jen Wei, John M. Lachin Controlled Clinical Trials UrologyClinical TrialsDrug TrialUrn Randomization	1988	305
Two-Sample Asymptotically Distribution-Free Tests for Incomplete Multivariate Observations Lee‐Jen Wei, John M. Lachin Journal of the American Statistical Association Log-rank TestsIncomplete Multivariate ObservationsAppropriate Test ScoresTime-varying ConfoundingBiostatistics	1984	294
Randomization in clinical trials: Conclusions and recommendations John M. Lachin, John P. Matts, Lee‐Jen Wei Controlled Clinical Trials Clinical Trial ManagementClinical EndpointStatisticsClinical TrialsRandomized Controlled Trial	1988	268
An Application of an Urn Model to the Design of Sequential Controlled Clinical Trials Lee‐Jen Wei Journal of the American Statistical Association Clinical EndpointPrognosisTreatment Plan EvaluationPrognostic AssessmentClinical Trials	1978	260
On the Restricted Mean Survival Time Curve in Survival Analysis Lihui Zhao, Brian Claggett, Lü Tian, Biometrics	2015	256
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio Kyongsun Pak, Hajime Uno, Dae Hyun Kim, JAMA Oncology	2017	251
Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic Eric Slud, Lee‐Jen Wei Journal of the American Statistical Association Repeated SignificanceTime-varying ConfoundingBiostatisticsAsymptotic Distribution TheoryModified Wilcoxon Statistic	1982	234

Page 1